SNHG5 has also been shown to enhance glycolytic flux in breast cancer through the miR-299/BACH1 axis, promoting the expression of glycolytic enzymes such as HK2, PFK1, and GAPDH [43]. This evidence concerns the gene GAPDH and breast carcinoma.